Cargando…

Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins

BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellu...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lamotte, Juliette Duchesne, Polentes, Jérôme, Roussange, Florine, Lesueur, Léa, Feurgard, Pauline, Perrier, Anselme, Nicoleau, Camille, Martinat, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647380/
https://www.ncbi.nlm.nih.gov/pubmed/34865655
http://dx.doi.org/10.1186/s13287-021-02665-3
Descripción
Sumario:BACKGROUND: The lack of physiologically relevant and predictive cell-based assays is one of the major obstacles for testing and developing botulinum neurotoxins (BoNTs) therapeutics. Human-induced pluripotent stem cells (hiPSCs)-derivatives now offer the opportunity to improve the relevance of cellular models and thus the translational value of preclinical data. METHODS: We investigated the potential of hiPSC-derived motor neurons (hMNs) optical stimulation combined with calcium imaging in cocultured muscle cells activity to investigate BoNT-sensitivity of an in vitro model of human muscle-nerve system. RESULTS: Functional muscle-nerve coculture system was developed using hMNs and human immortalized skeletal muscle cells. Our results demonstrated that hMNs can innervate myotubes and induce contractions and calcium transient in muscle cells, generating an in vitro human motor endplate showing dose-dependent sensitivity to BoNTs intoxication. The implementation of optogenetics combined with live calcium imaging allows to monitor the impact of BoNTs intoxication on synaptic transmission in human motor endplate model. CONCLUSIONS: Altogether, our findings demonstrate the promise of optogenetically hiPSC-derived controlled muscle-nerve system for pharmaceutical BoNTs testing and development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02665-3.